NASDAQ:RGC | Cash Flow Statement | Regencell Bioscience Holdings Ltd

Complete source-backed cash-flow history.

Available history
2019-06-30 to 2025-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-06-30-$3.58M-$3.11M$152,689.00$2.69M
2024-06-30-$4.3M-$4M$5,376.00$5.24M$102,282.00
2023-06-30-$5.87M-$4.96M$27,392.00$58,978.00$134,913.00
2022-06-30-$7.45M-$5.27M$780,876.00-$10.78M$22.41M
2021-06-30-$1.35M-$767,311.00$439,745.00
2020-06-30-$812,371.00-$726,573.00$117,837.00-$117,837.00$988,082.00
2019-06-30-$390,990.00-$390,990.00$480,994.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.